Get started
Author

Yaya Chu

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
2019 · Gaurav Nayyar, Yaya Chu, et al. · Frontiers in Oncology · 177
PDF
Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
2014 · Yaya Chu, Jessica Hochberg, et al. · Cancer Immunology Research · 174
Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes
2007 · Yaya Chu, Rajna Simic, et al. · The EMBO Journal · 131
PDF
Two Steps in Maf1-dependent Repression of Transcription by RNA Polymerase III
2004 · Neelam Desai, JaeHoon Lee, et al. · Journal of Biological Chemistry · 110
Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
2017 · Yaya Chu, Ashlin Yahr, et al. · OncoImmunology · 82
PDF
The Bur1 Cyclin-Dependent Protein Kinase Is Required for the Normal Pattern of Histone Methylation by Set2
2006 · Yaya Chu, Ann Sutton, et al. · Molecular and Cellular Biology · 79
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
2021 · Yaya Chu, Gaurav Nayyar, et al. · Journal for ImmunoTherapy of Cancer · 46
PDF
ABSTRACTS
2022 · Milner, J, Talano, J A, et al. · Pediatric Blood & Cancer · 43
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity
2014 · Prakash Satwani, Sejal Bavishi, et al. · Cytotherapy · 29
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
2023 · Morgan Anderson-Crannage, Alex M. Ascensión, et al. · Frontiers in Immunology · 25
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
2016 · Janet Ayello, Jessica Hochberg, et al. · Experimental Hematology · 23
PDF
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
2018 · Yaya Chu, Sanghoon Lee, et al. · OncoImmunology · 22
PDF
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity
2020 · Meisam Naeimi Kararoudi, Brian P. Tullius, et al. · Seminars in Hematology · 21
Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma
2019 · Yaya Chu, Aliza Gardenswartz, et al. · British Journal of Haematology · 21
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
2022 · Yaya Chu, Margaret Lamb, et al. · Current Treatment Options in Oncology · 17
PDF
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma
2021 · Stan Goldman, Matthew Barth, et al. · Leukemia · 16
Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma
2020 · Yaya Chu, Gaurav Nayyar, et al. · Journal for ImmunoTherapy of Cancer · 16
PDF
ROR1-Specific Chimeric Antigen Receptor (CAR) NK Cell Immunotherapy for High Risk Neuroblastomas and Sarcomas
2017 · Haein Park, Aradhana Awasthi, et al. · Transplantation and Cellular Therapy · 15
Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non‐Hodgkin lymphoma
2016 · Matthew J. Barth, Yaya Chu, et al. · British Journal of Haematology · 15
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
2024 · Yaya Chu, Meijuan Tian, et al. · Molecular Therapy Oncology · 14
Cloning of human myeloid-associated differentiation marker (MYADM) gene whose expression was up-regulated in NB4 cells induced by all-trans retinoic acid
2001 · Wanchang Cui, Long Yu, et al. · Molecular Biology Reports · 14
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 Dim NK cells
2019 · Evan Shereck, Nancy S Day, et al. · Innate Immunity · 12
PDF
Modification of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular Therapy
2016 · Yaya Chu, Allyson Flower, et al. · Methods in molecular biology · 11
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
2020 · Yaya Chu, Aradhana Awasthi, et al. · Oncotarget · 10
PDF
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
2022 · Aliza Gardenswartz, Brinda Mehta, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Works count: 125
Citation count: 1,217
H-index: 16
I10-index: 24
Year
Topic
Type